| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2022 | Jul 21, 2022 | Ruth Matthew R. Chief Commercial Officer | Sell | Opiant Pharmaceuticals, Inc. | OPNT | $10.62 | $11,512 | -3.50% |
| Aug 31, 2021 | Sep 01, 2021 | Ruth Matthew R. Chief Commercial Officer | Buy | Opiant Pharmaceuticals, Inc. | OPNT | $17.34 | $34,680 | +10.53% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.